Aim: To explore the perceptions of patients with prostate cancer undergoing androgen deprivation therapy towards mobile health interventions.
Design: The study employed a qualitative descriptive design.
Methods: Seventeen participants were recruited from tertiary care hospitals from November 2022 to June 2023. The collected data were subsequently analysed using a content analysis approach.
Results: The main themes were facilitators, barriers, information needs, emotional and social needs, and self-management needs. Facilitators for using mobile health included support from healthcare professionals and family, competitive design features and user-friendly interfaces. Barriers included negative past experiences with technology and a satisfactory current state of health. Informational support included those patients who expressed a desire for timely, accurate information integrated with traditional Chinese medical principles. Regarding emotional support, patients emphasised their independence, preferring not to burden family and friends, showing disinterest in mindfulness and relaxation therapies, and generally disliking online interactions with fellow patients. For self-management, medication reminders and rehabilitation guidance were seen as vital tools to enhance supportive care.
Conclusion: The study highlights the importance of customising mobile healthcare applications to meet unique needs among patients with prostate cancer and enhance their engagement and satisfaction. Understanding their specific preferences enables the development of more effective mobile healthcare applications.
Reporting Method: The COREQ checklist.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jocn.17718 | DOI Listing |
Prostate
March 2025
VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, Detroit, Michigan, USA.
Background: Socioeconomic status and geographical location contribute to disparities in localized prostate cancer (PCa) treatment. We examined the impact of area of deprivation index (ADI) on initial treatment type for localized PCa in a North-American cohort.
Methods: We performed a retrospective analysis of patients diagnosed with localized PCa, treated within Henry Ford Health (HFH), between 1995 and 2022, with available ADI-data.
Background And Objective: Prostate cancer (PCa) is a significant global health concern, ranking as the second most prevalent cancer among men worldwide. Genetic factors, particularly germline pathogenic variants (PVs) in DNA repair genes (DRGs), play a crucial role in PCa predisposition. Our study aimed to assess patients' adherence to a targeted PCa screening program targeting high-risk individuals with DRG PVs and evaluate the potential reduction in biopsy and MRI rates by employing our screening protocol.
View Article and Find Full Text PDFFront Physiol
February 2025
German Cancer Consortium (DKTK), Partner Site Freiburg, Heidelberg, Germany.
Introduction: Prostate cancer (PCa) is the most frequent diagnosed malignancy in male patients in Europe and radiation therapy (RT) is a main treatment option. However, current RT concepts for PCa have an imminent need to be rectified in order to modify the radiotherapeutic strategy by considering (i) the personal PCa biology in terms of radio resistance and (ii) the individual preferences of each patient.
Methods: To this end, a mechanistic multiscale model of prostate tumor response to external radiotherapeutic schemes, based on a discrete entity and discrete event simulation approach has been developed.
Eur Urol Open Sci
April 2025
Division of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan.
Background And Objective: Indocyanine green-guided sentinel lymph node dissection (ICG-SLND) has demonstrated good diagnostic accuracy for lymph node metastasis in prostate cancer. This study aims to perform a meta-analysis of the diagnostic accuracy of ICG-SLND at both the per-patient and the per-node level.
Methods: We conducted a literature search on PubMed and Embase for relevant studies published up to June 2024.
Cureus
February 2025
Department of Plastic and Aesthetic Surgery, Kitasato University School of Medicine, Sagamihara Kanagawa, JPN.
We report a rare case of a smooth muscle tumor of uncertain malignant potential arising in the inguinal soft tissue, requiring differential diagnosis from metastatic lymphadenopathy. The patient was a 74-year-old male. On the initial examination, a painless, elastic-firm mass measuring approximately 25 × 15 mm was palpated slightly cephalad and medial to the left inguinal region.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!